![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 05, 2014 9:59:24 PM
Re T&T: Seems obvious that you'd rather have the right to convert at VWAP rather than at a fixed $0.367, when the VWAP is currently well below that fixed level?
Anyway, really need to see the entire agreement to work out what's going on. If they do get a registration statement accepted, I think the agt will be attached to it; presumably it would be material enough for that.
Re the science work: I think clearly the goal should be to get a credible strategic pharma partner & doing so would go a long way to validating everything. I have no idea how likely that is or how much progress they would need to make before it becomes a realistic prospect.
For the peptide stuff, they still haven't gotten past the pre-clinical animal work; now saying it should be completed by 4th quarter. If you go back over their filings, they've been estimating "a few more months" to do this, for years. Maybe they'll actually get it done, finally. But if they rely on the Dutchess "financing" for it, they'll obviously have to do something to increase trading volumes. Will be interesting to watch.
One fundamental question: Assuming that Newell-Rogers is crucial to the work, how much time is she spending on it, given her demanding-sounding day job?
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM